HUT76334A - Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme - Google Patents
Bicyclic lactam inhibitor of interleukin-1-beta converting enzymeInfo
- Publication number
- HUT76334A HUT76334A HU9603376A HU9603376A HUT76334A HU T76334 A HUT76334 A HU T76334A HU 9603376 A HU9603376 A HU 9603376A HU 9603376 A HU9603376 A HU 9603376A HU T76334 A HUT76334 A HU T76334A
- Authority
- HU
- Hungary
- Prior art keywords
- interleukin
- converting enzyme
- beta converting
- bicyclic lactam
- lactam inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/255,276 US5552400A (en) | 1994-06-08 | 1994-06-08 | Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
PCT/US1995/007314 WO1995033751A1 (en) | 1994-06-08 | 1995-06-08 | Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9603376D0 HU9603376D0 (en) | 1997-01-28 |
HUT76334A true HUT76334A (en) | 1997-08-28 |
HU226979B1 HU226979B1 (en) | 2010-04-28 |
Family
ID=22967606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9603376A HU226979B1 (en) | 1994-06-08 | 1995-06-08 | Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme and pharmaceutical compositions containing them |
Country Status (13)
Country | Link |
---|---|
US (2) | US5552400A (hu) |
EP (2) | EP0764167B1 (hu) |
JP (1) | JP4173536B2 (hu) |
AT (2) | ATE252585T1 (hu) |
AU (1) | AU705882B2 (hu) |
CA (1) | CA2192360C (hu) |
DE (2) | DE69536064D1 (hu) |
DK (1) | DK0764167T3 (hu) |
ES (2) | ES2341949T3 (hu) |
HK (2) | HK1064102A1 (hu) |
HU (1) | HU226979B1 (hu) |
PT (1) | PT764167E (hu) |
WO (1) | WO1995033751A1 (hu) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008217A (en) * | 1995-12-20 | 1999-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US5874424A (en) * | 1995-12-20 | 1999-02-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
KR100856767B1 (ko) * | 1966-11-26 | 2009-06-16 | 버텍스 파마슈티칼스 인코포레이티드 | 인터류킨-1 베타 전환효소의 억제제 |
US5756466A (en) * | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
US6420522B1 (en) * | 1995-06-05 | 2002-07-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US5847135A (en) * | 1994-06-17 | 1998-12-08 | Vertex Pharmaceuticals, Incorporated | Inhibitors of interleukin-1β converting enzyme |
US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
US6699869B1 (en) * | 1995-03-24 | 2004-03-02 | Myriad Genetics Inc. | β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
US6245764B1 (en) * | 1995-03-24 | 2001-06-12 | Molecumetics Ltd. | β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
US6020331A (en) * | 1995-03-24 | 2000-02-01 | Molecumetics, Ltd. | β-sheet mimetics and use thereof as protease inhibitors |
US6162828A (en) * | 1995-03-31 | 2000-12-19 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
US5744451A (en) * | 1995-09-12 | 1998-04-28 | Warner-Lambert Company | N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
AU756253B2 (en) * | 1995-12-20 | 2003-01-09 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1beta converting enzyme |
US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
JP2000511882A (ja) * | 1996-04-12 | 2000-09-12 | ブリストル―マイヤーズ・スクイブ・カンパニー | Ace阻害剤及び/またはnep阻害剤として有用なn―ホルミルヒドロキシルアミン化合物 |
US6117896A (en) | 1997-02-10 | 2000-09-12 | Molecumetics Ltd. | Methods for regulating transcription factors |
JP2001508404A (ja) | 1996-10-11 | 2001-06-26 | ワーナー―ランバート・コンパニー | スルホンアミドインターロイキン―1β変換酵素阻害剤 |
US5919790A (en) * | 1996-10-11 | 1999-07-06 | Warner-Lambert Company | Hydroxamate inhibitors of interleukin-1β converting enzyme |
KR20000049050A (ko) * | 1996-10-11 | 2000-07-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 술폰아미드 치환된 아스파르트산 인터루킨-1β 전환 효소 억제제 |
DE69925581T2 (de) | 1998-03-09 | 2006-04-27 | Vertex Pharmaceuticals Inc., Cambridge | 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms |
KR100928878B1 (ko) | 1998-03-19 | 2009-11-30 | 버텍스 파마슈티칼스 인코포레이티드 | 카스파제의 억제제 |
WO1999051580A1 (en) * | 1998-04-08 | 1999-10-14 | Abbott Laboratories | Pyrazole inhibitors of cytokine production |
FR2777279B1 (fr) * | 1998-04-08 | 2004-08-13 | Hoechst Marion Roussel Inc | Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide |
AU2003200034B2 (en) * | 1998-04-27 | 2006-07-20 | Aventis Pharma S.A. | New derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-A][1,2]diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds |
FR2777889B1 (fr) * | 1998-04-27 | 2004-07-09 | Hoechst Marion Roussel Inc | Nouveaux derives de l'acide octahydro-6,10-dioxo-6h- pyridazino[1,2-a][1,2]diazepine-1-carboxylique, leur procede de preparation et leur application a la preparation de composes therapeutiquement actifs |
FR2802927B1 (fr) * | 1999-12-28 | 2002-03-01 | Hoechst Marion Roussel Inc | Nouveaux derives de diazepine carboxamide, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et leur nouvelle utilisation |
EP1712239A3 (en) * | 2000-05-12 | 2007-08-22 | Immunex Corporation | Interleukin-1 inhibitors in the treatment of diseases |
PE20011350A1 (es) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
JP2003535865A (ja) | 2000-06-07 | 2003-12-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | カスパーゼインヒビターおよびその使用 |
US7410956B2 (en) * | 2002-02-11 | 2008-08-12 | Vertex Pharmaceuticals Incorporated | Caspase inhibitor prodrugs |
JP2005526722A (ja) | 2002-02-14 | 2005-09-08 | ミリアド・ジェネティックス・インコーポレイテッド | β−シートミメティックならびにそれに関連する組成物および方法 |
US20070184021A1 (en) * | 2002-10-01 | 2007-08-09 | Daohong Zhou | Use of caspase inhibitors as a therapeutic agent against radiation-induced injury |
AU2005247409B2 (en) * | 2004-05-15 | 2011-11-10 | Vertex Pharmaceuticals Incorporated | Treating seizures using ICE inhibitors |
EP1778221A2 (en) * | 2004-05-27 | 2007-05-02 | Vertex Pharmaceuticals Incorporated | Ice inhibitors for the treatment of autoinflammatory diseases |
EP2635906A4 (en) | 2010-11-05 | 2014-04-02 | Univ Brandeis | ICE INHIBITING COMPOUNDS AND USES THEREOF |
US9956260B1 (en) | 2011-07-22 | 2018-05-01 | The J. David Gladstone Institutes | Treatment of HIV-1 infection and AIDS |
US9180193B2 (en) * | 2011-10-10 | 2015-11-10 | Hoffmann-La Roche Inc. | Antiviral compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3062972D1 (en) * | 1979-09-19 | 1983-06-09 | Hoffmann La Roche | Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives |
EP0042100A1 (de) * | 1980-06-13 | 1981-12-23 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel |
ZA833214B (en) * | 1982-05-12 | 1983-12-28 | Hoffmann La Roche | Bicyclic compounds |
JP2543503B2 (ja) * | 1986-07-01 | 1996-10-16 | 綜研化学株式会社 | 分岐構造を有する共重合体を分散安定剤として用いた乳化重合法 |
DE69226820T2 (de) * | 1991-06-21 | 1999-05-12 | Merck & Co., Inc., Rahway, N.J. | Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen |
GB9123326D0 (en) * | 1991-11-04 | 1991-12-18 | Sandoz Ltd | Improvements in or relating to organic compounds |
AU3666893A (en) * | 1992-02-21 | 1993-09-13 | Merck & Co., Inc. | Peptidyl derivatives as inhibitors of interleukin-1beta converting enzyme |
DK0640086T3 (da) * | 1992-05-15 | 1999-12-06 | Merrell Pharma Inc | Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer |
EP0618223A3 (en) * | 1993-03-08 | 1996-06-12 | Sandoz Ltd | Peptides, the release of Interleukin 1-Bêta, useful as anti-inflammatory agents. |
-
1994
- 1994-06-08 US US08/255,276 patent/US5552400A/en not_active Expired - Lifetime
-
1995
- 1995-05-25 US US08/451,108 patent/US5639745A/en not_active Expired - Lifetime
- 1995-06-08 AU AU27699/95A patent/AU705882B2/en not_active Ceased
- 1995-06-08 ES ES03018280T patent/ES2341949T3/es not_active Expired - Lifetime
- 1995-06-08 JP JP50131596A patent/JP4173536B2/ja not_active Expired - Fee Related
- 1995-06-08 AT AT95923013T patent/ATE252585T1/de not_active IP Right Cessation
- 1995-06-08 EP EP95923013A patent/EP0764167B1/en not_active Expired - Lifetime
- 1995-06-08 DE DE69536064T patent/DE69536064D1/de not_active Expired - Lifetime
- 1995-06-08 WO PCT/US1995/007314 patent/WO1995033751A1/en active IP Right Grant
- 1995-06-08 PT PT95923013T patent/PT764167E/pt unknown
- 1995-06-08 DE DE69531990T patent/DE69531990T2/de not_active Expired - Lifetime
- 1995-06-08 DK DK95923013T patent/DK0764167T3/da active
- 1995-06-08 AT AT03018280T patent/ATE464314T1/de not_active IP Right Cessation
- 1995-06-08 EP EP03018280A patent/EP1391461B1/en not_active Expired - Lifetime
- 1995-06-08 HU HU9603376A patent/HU226979B1/hu not_active IP Right Cessation
- 1995-06-08 CA CA002192360A patent/CA2192360C/en not_active Expired - Fee Related
- 1995-06-08 ES ES95923013T patent/ES2210294T3/es not_active Expired - Lifetime
-
1998
- 1998-12-17 HK HK04106255.3A patent/HK1064102A1/xx not_active IP Right Cessation
- 1998-12-17 HK HK98113969A patent/HK1012630A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1064102A1 (en) | 2005-01-21 |
EP1391461A1 (en) | 2004-02-25 |
HK1012630A1 (en) | 1999-08-06 |
US5552400A (en) | 1996-09-03 |
HU9603376D0 (en) | 1997-01-28 |
CA2192360A1 (en) | 1995-12-14 |
ES2341949T3 (es) | 2010-06-30 |
MX9606192A (es) | 1998-06-30 |
AU705882B2 (en) | 1999-06-03 |
PT764167E (pt) | 2004-03-31 |
US5639745A (en) | 1997-06-17 |
ATE252585T1 (de) | 2003-11-15 |
WO1995033751A1 (en) | 1995-12-14 |
DE69536064D1 (de) | 2010-05-27 |
DE69531990T2 (de) | 2004-09-02 |
AU2769995A (en) | 1996-01-04 |
EP0764167B1 (en) | 2003-10-22 |
JP4173536B2 (ja) | 2008-10-29 |
HU226979B1 (en) | 2010-04-28 |
CA2192360C (en) | 2007-08-07 |
EP0764167A1 (en) | 1997-03-26 |
EP1391461B1 (en) | 2010-04-14 |
EP0764167A4 (en) | 1997-09-17 |
JPH10501244A (ja) | 1998-02-03 |
ATE464314T1 (de) | 2010-04-15 |
DK0764167T3 (da) | 2004-02-09 |
DE69531990D1 (de) | 2003-11-27 |
ES2210294T3 (es) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9603376D0 (en) | Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme | |
BG102872A (en) | 6-phenylpyridyl-3-amine derivatives | |
GR3026222T3 (en) | Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | |
HU9403323D0 (en) | 4-mercaptioacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors | |
ES2122145T3 (es) | Fosfiniloximetil-cetonas peptidicas como inhibidores de la enzima convertida de la interleuquina-1 beta. | |
EP0563345A4 (en) | Novel 4-arylpiperazines and 4-arylpiperidines | |
MX9700557A (es) | Dihidrobenzofuranos. | |
GR3024884T3 (en) | New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors | |
MY111201A (en) | New imidazopyridines | |
GR3033661T3 (en) | Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace | |
AU658296B2 (en) | 7 beta-substituted-4-aza-5 alpha-cholestan-3-ones as 5 alpha-reductase inhibitors | |
AU579971B2 (en) | Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents | |
HK1033096A1 (en) | Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculationdisorders | |
EP0406211A3 (en) | Fucosidase inhibitors | |
AP9400632A0 (en) | Ether derivatives. | |
MX9500228A (es) | N-oxidos de 4-arilpiperazinas y 4-arilpiperidinas. | |
DE69625910D1 (de) | Penamsulfone als beta-laktamase inhibitoren | |
BG104373A (en) | Polymorphous forms of dofetilide | |
IL107242A0 (en) | Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates | |
AU2163588A (en) | Stabilization of enzymes by inhibiting proteolytic enzyme contaminants | |
EP0297816A3 (en) | Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents | |
GR3032850T3 (en) | Use of hydrolytic enzyme for reducing or preventing side effects of bleomycine. | |
ES2065843A1 (es) | Aplicacion de ent-11 , 16-dihidroxi-18-nor-4a -carboximetil-oxido de manoilo como inhibidor de la adenilatociclasa. | |
GR3007684T3 (hu) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DGB9 | Succession in title of applicant |
Owner name: VERTEX PHARMACEUTICALS INCORPORATED, US |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |